drugset / Trial / NCT00596596

Trial to Evaluate the Efficacy and Safety of R093877 in Patients With Chronic Idiopathic Constipation

NCT00596596

Phase 2 Completed 313 enrolled Movetis
RandomizedParallel-groupDouble-blindTreatment

Summary

The purpose of the study is to determine whether prucalopride is safe and effective in patients with chronic idiopathic constipation. Hypothesis: At all doses administered prucalopride given once daily for 4 weeks is safe and well tolerated in patients with chronic idiopathic constipation.

Timeline

Start
1996-09
Primary completion
1997-06
Completion
1997-06

Drugs

EvaluationDrugModalityDoseRoute
Comparator Prucalopride Small molecule 0.5 mg
Comparator Prucalopride Small molecule 1 mg
Comparator Prucalopride Small molecule 2 mg
Comparator Prucalopride Small molecule 4 mg

Indications